Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

GFR alpha-4/GDNF R alpha-4/Persephin receptor Antibody (MM0311-3P34) - Azide and BSA Free, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$206.50 - $560.50

Specifications

Antigen GFR alpha-4/GDNF R alpha-4/Persephin receptor
Clone MM0311-3P34
Concentration LYOPH
Applications Western Blot
Classification Monoclonal
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NB019202
SDP
View Documents
Novus Biologicals
NBP2124140.025MG
0.025 mg
Each for $206.50
Only null left
Add to Cart
 
NBP212414
SDP
View Documents
Novus Biologicals
NBP212414
0.1 mg
Each for $560.50
Only null left
Add to Cart
 
Description

Description

GFR alpha-4/GDNF R alpha-4/Persephin receptor Monoclonal specifically detects GFR alpha-4/GDNF R alpha-4/Persephin receptor in Human samples. It is validated for Western Blot.
Specifications

Specifications

GFR alpha-4/GDNF R alpha-4/Persephin receptor
LYOPH
Monoclonal
Purified
RUO
NP_071422
64096
IgG1
Protein G purified
MM0311-3P34
Western Blot
Unconjugated
Mouse
Human
GDNF family receptor alpha 4, GDNF family receptor alpha-4, GDNF receptor alpha-4, GDNFR-alpha-4, GFR receptor alpha 4, GFR-alpha-4, Persephin receptor
GFRA4
Primary
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Videos
SDS
Documents

Documents

Product Certifications

For Research Use Only

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.